Sanford-Burnham News Archive

University of Florida President Appointed to Sanford-Burnham’s Board of Trustees

ORLANDO, Fla. , February 22, 2012

Sanford-Burnham Medical Research Institute (Sanford-Burnham) today announced that University of Florida (UF) President Bernie Machen has joined its Board of Trustees. Dr. Machen will be the fourth Floridian to serve on the Institute’s board. Current Florida-based trustees include Allen R. Weiss, former president of Walt Disney Parks and Resorts, and James E. Jardon II, chief executive officer of JHT, Incorporated. Previously serving as a Trustee was Robert Mandell of Orlando, Florida, now U.S. ambassador to Luxembourg.

“As president of one of Florida’s leading research universities, I am honored to join Sanford-Burnham’s Board of Trustees,” said Machen. “My relationship with Sanford-Burnham dates back to 2006, when the Institute first considered opening a new campus in Orlando. Over the years we’ve developed strategies that will benefit our individual and shared scientific endeavors. I look forward to my role on the board and the many new partnership opportunities to come.”

Bernie Machen, President, University of FloridaBernie Machen, President, University of Florida

Machen was appointed UF’s 11th president in January, 2004. During his tenure, he has expanded the university’s research and scholarship endeavors, elevated its educational programs and increased access to students from diverse economic backgrounds – all while shepherding the university through an era of growing financial challenges. A member of the Florida Council of 100, he has held several prominent positions in statewide and national higher education. He earned his doctor of dental surgery from St. Louis University and doctorate in educational psychology from the University of Iowa, both of which have honored him with distinguished alumnus awards.

“We are thrilled to have Bernie join our Board of Trustees. His longtime support of our Institute and commitment to furthering medical research make him a perfect fit. With the opening later this year of UF’s Research and Academic Center adjacent to our Orlando campus, we welcome a new Medical City neighbor and superb partner,” said John C. Reed, MD, Ph.D., Sanford-Burnham’s CEO.

Already, researchers at Sanford-Burnham and UF are exploring opportunities for collaborations in such fields as diabetes and aging. Several Sanford-Burnham faculty members also hold joint faculty appointments at UF, including Dr. Reed who is an Adjunct Professor.

A complete list of Sanford-Burnham’s trustees can be found at http://www.sanfordburnham.org/talent/Pages/Home.aspx#trustees_Honorary.

About Sanford-Burnham Medical Research Institute


Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs 1,200 scientists and staff in San Diego (La Jolla), California and Orlando (Lake Nona), Florida. For more information, visit us at sanfordburnham.org.

News & News and Press - Sanford-Burnham Boilerplate
Sign In Skip Navigation Links Skip navigation links
News Archive
Sanford-Burnham In The News
Media Contacts and Guidelines
News Search
Paper of the Week
Multimedia Resources